Clinical benefits, echocardiographic and MRI assessment after pulmonary sequestration treatment

Francesco Borgia1, Francesca Santamaria2, Carmine Mollica3

  • 1Department of Advanced Biomedical Sciences, Divisions of Cardiology and Cardiothoracic Surgery, Federico II University, Naples, Italy.

Insights

Percutaneous treatment for pulmonary sequestration (PS) in children is safe and effective, leading to symptom improvement and reduced heart enlargement. MRI confirms treatment success and monitors residual PS, aiding in long-term management.

Area of Science:

  • Pediatric Interventional Cardiology
  • Thoracic Imaging
  • Vascular Malformations

Background:

  • Pulmonary sequestration (PS) is a congenital lung malformation with potential for significant clinical impact.
  • Percutaneous treatment offers a minimally invasive approach to address the aberrant artery supplying PS.

Purpose of the Study:

  • To evaluate the procedural outcomes and clinical benefits of percutaneous treatment for pulmonary sequestration (PS).
  • To assess the efficacy of echocardiography and chest MRI in monitoring treatment effects on cardiac function and PS regression.

Main Methods:

  • A cohort of 13 infants and children with isolated PS underwent percutaneous closure of the aberrant feeding artery.
  • Echocardiography and chest MRI were performed pre- and post-treatment (6-12 months and 1 year) to assess cardiac volume overload and PS regression.

Main Results:

  • 100% procedural success was achieved in all patients.
  • Respiratory symptoms resolved post-treatment, with sustained asymptomatic status at a median follow-up of 2.9 years.
  • Significant reduction in cardiac chamber enlargement was observed in patients with shunts, confirmed by imaging at 6 and 12 months.
  • Chest MRI confirmed aberrant artery closure and PS regression in 12 patients; one case showed residual revascularization despite initial success.

Conclusions:

  • Percutaneous PS closure is a safe and effective treatment for infants and children, leading to symptom regression and improved cardiac function when shunts are present.
  • Chest MRI is a valuable tool for defining aberrant artery anatomy, assessing PS, and monitoring residual disease during patient growth.
Abstract

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
367
Imaging Studies for Cardiovascular System II:Types of Echocardiography01:20

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
732
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
563
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
856
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
386
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
1.2K